PP
RCPI

Paloma Partners’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Paloma Partners’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-26,375
Closed -$389K – 1545
2014
Q2 		$389K Buy
+26,375
New +$458K 0.02% 703

Other funds holding RCPI

GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

Paloma Partners's RCPI Position: Q3 2014 in Review

Paloma Partners sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q3 2014, closing a stake of 26,375 shares — an estimated $389K sold.

Paloma Partners first reported a position in RCPI in Q2 2014 and held it in 1 quarter. The position peaked at $389K in Q2 2014. 67 funds tracked by Wall St. Rank hold RCPI as of Q3 2014.

  • Paloma Partners reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Paloma Partners sold 26,375 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $389K.
  • Paloma Partners first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Paloma Partners's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $389K in Q2 2014.
  • 67 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Paloma Partners's 13F filing for Q3 2014, filed 14 Nov 2014.